D-serine and Cognitive Remediation in Schizophrenia
NCT02156908
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
8
Enrollment
OTHER
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
D-serine
Sponsor
Nathan Kline Institute for Psychiatric Research